[Local drug therapy for inner ear hearing loss].

Abstract

The indications for local drug therapy of inner ear hearing loss include sudden sensorineural hearing loss, Menière's disease, autoimmune-associated hearing loss, ototoxicity as a side effect of other therapies, acute acoustic trauma and improvement of the safety and performance of cochlear implants. Various drugs are currently being used and tested for local treatment of inner ear hearing loss, including glucocorticoids, growth factors, apoptosis inhibitors, antioxidants, TNF-α inhibitors and antibodies. To further a better understanding of pharmacokinetics and the development of rational pharmacotherapy of the inner ear, the"liberation, absorption, distribution, metabolism, elimination" (LADME) principle can be applied to local therapy of the inner ear. Local application strategies can be differentiated into intratympanic applications to the middle ear cavity and direct intralabyrinthine or intracochlear applications.

• Authors: A Liebau, S K Plontke
• Journal: HNO (HNO) Vol. 63 Issue 6 Pg. 396-401 (Jun 2015) ISSN: 1433-0458 [Electronic] Germany
• Vernacular Title: Lokale Medikamententherapie bei Innenohrschwerhörigkeit.
• PMID: 25008276 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Antioxidants
• Glucocorticoids
• Inhibitor of Apoptosis Proteins
• Intercellular Signaling Peptides and Proteins

Topics

• Administration, Topical
• Antioxidants (administration & dosage)
• Ear, Inner
• Evidence-Based Medicine
• Glucocorticoids (administration & dosage)
• Hearing Loss, Sensorineural (diagnosis, drug therapy)
• Humans
• Inhibitor of Apoptosis Proteins (administration & dosage)
• Intercellular Signaling Peptides and Proteins (administration & dosage)
• Molecular Targeted Therapy (methods)
• Treatment Outcome